stockrowBeOne Medicines Ltd. - Sponsored ADR
BeOne Medicines Ltd. - Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $5.3 billion, up 40.2% from fiscal 2024.
- Revenue
- +33.8%
- EPS
- +143.7%
- Free cash flow
- +33.6%
- Total debt
- +491.3%
Quarter to September 2026, against a year earlier
Follow ONC
Alert me
BeOne Medicines Ltd. - Sponsored ADR (ONC) Free cash flow
BeOne Medicines Ltd. - Sponsored ADR's free cash flow for fiscal 2025 was $921.7M, compared with −$638.0M in fiscal 2024. Over the twelve months to 30 September 2026 it was $1.4B. Over the past ten years it has ranged from −$1.8B (fiscal 2022) to $921.7M (fiscal 2025) — the current reading is the highest in ten years. Free cash flow has risen for 3 consecutive fiscal years. BeOne Medicines Ltd. - Sponsored ADR ranks 4th of 603 Biotechnology companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $921.7M | — |
| FY2024 | −$638.0M | — |
| FY2023 | −$1.7B | — |
| FY2022 | −$1.8B | — |
| FY2021 | −$1.6B | — |
| FY2020 | −$1.4B | — |
| FY2019 | −$839.9M | — |
| FY2018 | −$656.9M | — |
| FY2017 | −$46.0M | — |
| FY2016 | −$113.0M | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $473.5M | 8.77% |
| Jun 2026 | $435.3M | 171.16% |
| Mar 2026 | $160.5M | (57.73%) |
| Dec 2025 | $379.8M | 7.15% |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| RPRX Royalty Pharma PLC compare | $3.0B |
| ONC BeOne Medicines Ltd. - Sponsored ADR | $1.4B |
| ARGX argenex SE compare | $1.4B |
| INCY Incyte Corporation compare | $679.9M |
| BNTX BioNTech SE Sponsored ADR compare | −$524.1M |
| INSM Insmed, Inc. compare | −$627.6M |
| ROIV Roivant Sciences Ltd. compare | −$821.1M |
| RVMD Revolution Medicines, Inc. compare | −$1.4B |
| GMAB Genmab A/S Sponsored ADR compare | −$6.3B |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on ONC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement